Showing results (571-580 of 584) with videos related to
Sort By:
Pageof 59
Nature|December 1, 2020
A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidateLorena Sanchez-Felipe, Thomas Vercruysse, Sapna Sharma, et al.Nature|July 19, 2021
Broad sarbecovirus neutralization by a human monoclonal antibodyM Alejandra Tortorici, Nadine Czudnochowski, Tyler N Starr, et al.Biorxiv : the Preprint Server for Biology|April 14, 2021
Structural basis for broad sarbecovirus neutralization by a human monoclonal antibodyM Alejandra Tortorici, Nadine Czudnochowski, Tyler N Starr, et al.Science (New York, N.Y.)|October 20, 2022
Imprinted antibody responses against SARS-CoV-2 Omicron sublineagesYoung-Jun Park, Dora Pinto, Alexandra C Walls, et al.Biorxiv : the Preprint Server for Biology|June 9, 2022
Imprinted antibody responses against SARS-CoV-2 Omicron sublineagesYoung-Jun Park, Dora Pinto, Alexandra C Walls, et al.Nature|March 27, 2025
A small-molecule SARS-CoV-2 inhibitor targeting the membrane proteinEllen Van Damme, Pravien Abeywickrema, Yanting Yin, et al.Nature|March 27, 2025
A coronavirus assembly inhibitor that targets the viral membrane proteinManon Laporte, Dirk Jochmans, Dorothée Bardiot, et al.The Journal of Experimental Medicine|July 5, 2019
Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccinesNicholas Hernandez, Giorgia Bucciol, Leen Moens, et al.Global Health Action|October 24, 2019
ZikaPLAN: addressing the knowledge gaps and working towards a research preparedness network in the AmericasAnnelies Wilder-Smith, Raman Preet, Elizabeth B Brickley, et al.Nature|July 14, 2021
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escapeTyler N Starr, Nadine Czudnochowski, Zhuoming Liu, et al.Pageof 59